These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 23418644)

  • 1. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2011 Jan; (1):CD004896. PubMed ID: 21249666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrinolytic drugs for acute traumatic injury.
    Ker K; Roberts I; Shakur H; Coats TJ
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic drugs for acute traumatic injury.
    Coats T; Roberts I; Shakur H
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004896. PubMed ID: 15495129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
    Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
    Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2001; (1):CD001886. PubMed ID: 11279735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical application of tranexamic acid for the reduction of bleeding.
    Ker K; Beecher D; Roberts I
    Cochrane Database Syst Rev; 2013 Jul; (7):CD010562. PubMed ID: 23881695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to decrease blood loss and transfusion requirements for liver transplantation.
    Gurusamy KS; Pissanou T; Pikhart H; Vaughan J; Burroughs AK; Davidson BR
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009052. PubMed ID: 22161443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
    Engelen ET; Schutgens RE; Mauser-Bunschoten EP; van Es RJ; van Galen KP
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012293. PubMed ID: 29963686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid for reducing mortality in emergency and urgent surgery.
    Perel P; Ker K; Morales Uribe CH; Roberts I
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD010245. PubMed ID: 23440847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
    Henry D; Carless P; Fergusson D; Laupacis A
    CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical interventions for traumatic hyphema.
    Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD005431. PubMed ID: 21249670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.